Benitec Biopharma Inc.

Healthcare · Biotechnology · United States

Last price 8.74 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 304.88M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence...